Stati Uniti - inglese - NLM (National Library of Medicine)

avkare - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg - raloxifene hydrochloride tablets usp are indicated for the treatment and prevention of osteoporosis in postmenopausal women [ see clinical studies ( 14.1, 14.2) ]. raloxifene hydrochloride tablets usp are indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis [ see clinical studies ( 14.3) ]. raloxifene hydrochloride tablets usp are indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer [ see clinical studies ( 14.4) ]. the effect in the reduction in the incidence of breast cancer was shown in a study of postmenopausal women at high risk for breast cancer with a 5 year planned duration with a median follow-up of 4.3 years [ see clinical studies ( 14.4) ]. twenty-seven percent of the participants received drug for 5 years. the long-term effects and the recommended l

Stati Uniti - inglese - NLM (National Library of Medicine)

apotheca, inc. - propoxyphene napsylate (unii: 38m219l1oj) (propoxyphene - unii:s2f83w92tk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - propoxyphene napsylate 100 mg - propoxyphene napsylate and acetaminophen tablets are contraindicated in patients with known hypersensitivity to propoxyphene or acetaminophen. propoxyphene napsylate and acetaminophen tablets are contraindicated in patients with significant respiratory depression (in unmonitored settings or the absence of resuscitative equipment) and patients with acute or severe asthma or hypercarbia. propoxyphene napsylate and acetaminophen tablets are contraindicated in any patient who has or is suspected of having paralytic ileus. propoxyphene napsylate and acetaminophen tablets are a schedule iv narcotic under the u.s. controlled substances act. propoxyphene napsylate and acetaminophen tablets can produce drug dependence of the morphine type, and therefore, has the potential for being abused. psychic dependence, physical dependence and tolerance may develop upon repeated administration. propoxyphene napsylate and acetaminophen tablets should be prescribed and administered with the same degree of caution appro

Stati Uniti - inglese - NLM (National Library of Medicine)

andrx pharmaceuticals, inc. - propoxyphene napsylate (unii: 38m219l1oj) (propoxyphene - unii:s2f83w92tk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - tablet, film coated - 100 mg - propoxyphene napsylate and acetaminophen tablets, 100 mg/500 mg are indicated for the relief of mild to moderate pain, either when pain is present alone or when it is accompanied by fever. contraindications hypersensitivity to propoxyphene or acetaminophen.

Stati Uniti - inglese - NLM (National Library of Medicine)

watson laboratories, inc. - propoxyphene hydrochloride (unii: cb2tl9ps0t) (propoxyphene - unii:s2f83w92tk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - tablet - 65 mg - propoxyphene hydrochloride and acetaminophen tablets are indicated for the relief of mild-to-moderate pain, either when pain is present alone or when it is accompanied by fever. hypersensitivity to propoxyphene or to acetaminophen.

Stati Uniti - inglese - NLM (National Library of Medicine)

andrx pharmaceuticals, inc. - propoxyphene napsylate (unii: 38m219l1oj) (propoxyphene - unii:s2f83w92tk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - tablet, film coated - propoxyphene napsylate and acetaminophen tablets, 100 mg/650 mg are indicated for the relief of mild to moderate pain, either when pain is present alone or when it is accompanied by fever. hypersensitivity to propoxyphene or acetaminophen

Australia - inglese - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - raloxifene hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: povidone; magnesium stearate; citric acid monohydrate; macrogol 400; polysorbate 80; titanium dioxide; hypromellose; microcrystalline cellulose; crospovidone - raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - raloxifene hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: hypromellose; crospovidone; macrogol 400; microcrystalline cellulose; magnesium stearate; titanium dioxide; povidone; citric acid monohydrate; polysorbate 80 - raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.

Stati Uniti - inglese - NLM (National Library of Medicine)

redpharm drug inc. - propoxyphene napsylate (unii: 38m219l1oj) (propoxyphene - unii:s2f83w92tk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - propoxyphene napsylate 100 mg

Israele - inglese - Ministry of Health

teva israel ltd - raloxifene hydrochloride - tablets - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - - treatment of osteoporosis in post menopausal women.- prevention of osteoporosis in post menopausal women.- reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. - reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.

Israele - inglese - Ministry of Health

teva israel ltd - raloxifene hydrochloride - tablets - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - - treatment of osteoporosis in post menopausal women.- prevention of osteoporosis in post menopausal women.- reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. - reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.